Meeting
2020 Gastrointestinal Cancers Symposium
Insurance status and cholangiocarcinoma: A NCDB analysis.
Authors
Hibah Ahmed
Creighton University School of Medicine, Omaha, NE
Hibah Ahmed , Nathan Law , Katrina Wolfe , Peter T. Silberstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 500)
Abstract #
500
Poster Bd #
B3
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Insurance status and hepatocellular carcinoma: A NCDB analysis.
First Author: Hibah Ahmed
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Disparities in surgical outcomes and survival based on insurance status among patients with fibrolamellar hepatocellular carcinoma: A national perspective.
First Author: Alec Czaplicki
Poster
2020 ASCO Virtual Scientific Program
Health insurance status and cancer stage at diagnosis and survival in the United States.
First Author: Jingxuan Zhao
Poster
2017 ASCO Annual Meeting
Impact of insurance status on treatment for stage 0-IV breast cancer.
First Author: Rachel Adams Greenup